Reversal of the CD4+/CD8+ T-cell ratio in lymph node cells upon in vitro mitogenic stimulation by highly purified, water-soluble S3-S4 dimer of pertussis toxin

Infection and Immunity

Volumn 69, Issue 5, 2001, Pages 3073-3081

  Latif, R ^a   Kerlero de Rosbo, N ^a   Amarant, T ^a   Rappuoli, R ^a   Sappler, G ^a   Ben Nun, A ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

DIMER; PERTUSSIS TOXIN;

ANIMAL CELL; ARTICLE; BORDETELLA PERTUSSIS; CONTROLLED STUDY; IMMUNOMODULATION; IMMUNOPHARMACOLOGY; LYMPH NODE CELL; LYMPHOCYTE COUNT; MITOGENESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; TOXIN STRUCTURE;

ANIMALS; BLOTTING, WESTERN; CD4-CD8 RATIO; CHROMATOGRAPHY, GEL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DIMERIZATION; LYMPH NODES; MICE; MITOGENS; PERTUSSIS TOXIN; PROTEIN SUBUNITS; RECOMBINANT FUSION PROTEINS; VIRULENCE FACTORS, BORDETELLA;

EID: 0035061753     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.69.5.3073-3081.2001     Document Type: Article

References (37)

1. Pertussis holotoxoid formed in vitro with a genetically deactivated S1 subunit
2. Detection of cells responding to myelin basic protein by proliferation and selection of T cell lines functional in mediating experimental autoimmune encephalomyelitis in mice
3. Immunomodulation of murine experimental autoimmune encephalomyelitis by pertussis toxin: The protective activity, but not the disease-enhancing activity, can be attributed to the nontoxic B-oligomer
4. Protection against autoimmune disease by bacterial agents. II. PPD and pertussis toxin as proteins active in protecting mice against experimental autoimmune encephalomyelitis
5. ADP-ribosyltransferase activity of pertussis toxin and immunomodulation by Bordetella pertussis
6. Therapy with monoclonal antibodies by elimination of T-cell subsets in vivo
7. Characterization of the murine T cell surface molecule, designated L3T4, identified by monoclonal antibody GK1.5: Similarity of L3T4 to the human Leu-3/T4 molecule
8. ADP-ribosylation of signal-transducing guanine nucleotide-binding proteins by pertussis toxin
9. Pertussis toxin effects on T lymphocytes are mediated through CD3 and not by pertussis toxin catalyzed modification of a G protein
10. Binding of pertussis toxin to lipid vesicles containing glycolipids
11. Investigation of the lectin-like binding domains in pertussis toxin using synthetic peptide sequences
12. Chronic relapsing experimental autoimmune encephalomyelitis with a delayed onset and an atypical clinical course, induced in PL/J mice by myelin oligodendrocyte glycoprotein (MOG)-derived peptide: Preliminary analysis of MOG T cell epitopes
13. Pertussis toxin analog with reduced enzymatic and biological activities is a protective immunogen
14. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
15. Site-specific alterations in the B-oligomer that affect receptor-binding activities and mitogenicity of pertussis toxin
16. Characterization of pertussis toxin analogs containing mutations in B-oligomer subunits
17. b mice. Fine specificity and T cell receptor Vb expression of encephalitogenic T cells
18. Biological activities of pertussigen (pertussis toxin)
19. Expression and immunological properties of the five subunits of pertussis toxin
20. Chemical modification of islet-activating protein, pertussis toxin. Essential role of free amino groups in its lymphocytosis-promoting activity
21. Dual mechanisms involved in development of diverse biological activities of islet-activating protein, pertussis toxin, as revealed by chemical modifications of lysine residues in the toxin molecule
22. Structure-function relationship of islet-activating protein, pertussis toxin: Biological activities of hybrid toxins reconstituted from native and methylated subunits
23. The lymphocytosis-promoting agent pertussis toxin affects virus burden and lymphocyte distribution in the SIV-infected rhesus macaque
24. Mutants of pertussis toxin suitable for vaccine development
25. An activated form of Notch influences the choice between CD4 and CD8 T cell lineages
26. Pertussis toxin has eukaryotic-like carbohydrate recognition domains
27. Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa
28. The crystal structure of pertussis toxin
29. Human T lymphocyte mitogenesis in response to the B oligomer of pertussis toxin is associated with an early elevation in cytosolic calcium concentrations
30. Pertussis toxin can replace T cell receptor signals that induce positive selection of CD8 T cells
31. A role of the B-oligomer moiety of islet-activating protein, pertussis toxin, in development of the biological effects on intact cells
32. Subunit structure of islet-activating protein, pertussis toxin, in conformity with the A-B model
33. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications
34. Role of carbohydrate recognition domains of pertussis toxin in adherence of Bordetella pertussis to human macrophages
35. Virulence factors of Bordetella pertussis
36. Interaction of pertussis toxin with human T lymphocytes
37. Binding of pertussis toxin to eucaryotic cells and glycoproteins